Acadian Asset Management LLC Dexcom Inc Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 113,416 shares of DXCM stock, worth $9.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

113,416

Previous 24,539 362.19%

Holding current value

$9.1 Million

Previous $2.78 Million 173.43%

% of portfolio

0.02%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $5.69 Million - $10.3 Million	88,877 Added 362.19%	113,416 $7.6 Million
Q2 2024 Aug 06, 2024	BUY	$110.31 - $140.45 $1.82 Million - $2.32 Million	16,531 Added 206.43%	24,539 $2.78 Million
Q1 2024 May 10, 2024	BUY	$114.22 - $140.1 $262,591 - $322,089	2,299 Added 40.27%	8,008 $1.11 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $1,358 - $2,234	18 Added 0.32%	5,709 $707,000
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $1.6 Million - $2.56 Million	-18,573 Reduced 76.55%	5,691 $530,000
Q2 2023 Aug 07, 2023	SELL	$112.47 - $130.98 $609,474 - $709,780	-5,419 Reduced 18.26%	24,264 $3.11 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $723,424 - $855,031	6,956 Added 30.61%	29,683 $3.45 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $1.89 Million - $2.73 Million	22,240 Added 4566.74%	22,727 $2.57 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $159,800 - $197,118	-2,093 Reduced 81.12%	487 $39,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $156,309 - $305,514	2,299 Added 818.15%	2,580 $192,000
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $25,119 - $34,763	-267 Reduced 48.72%	281 $143,000
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $129 - $162	-1 Reduced 0.18%	548 $294,000
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $84,941 - $113,971	-796 Reduced 59.18%	549 $299,000
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $56,450 - $75,227	697 Added 107.56%	1,345 $574,000
Q1 2021 May 11, 2021	SELL	$84.79 - $104.74 $110,905 - $136,999	-1,308 Reduced 66.87%	648 $233,000
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $71,136 - $95,304	-912 Reduced 31.8%	1,956 $723,000
Q3 2020 Nov 09, 2020	BUY	$95.51 - $112.95 $62,845 - $74,321	658 Added 29.77%	2,868 $1.18 Million
Q2 2020 Aug 12, 2020	SELL	$62.68 - $105.34 $2.56 Million - $4.3 Million	-40,860 Reduced 94.87%	2,210 $896,000
Q1 2020 May 11, 2020	BUY	$47.79 - $75.63 $1.95 Million - $3.09 Million	40,903 Added 1887.54%	43,070 $11.6 Million
Q4 2019 Feb 06, 2020	BUY	$36.62 - $57.29 $79,355 - $124,147	2,167 New	2,167 $475,000
Q2 2019 Aug 08, 2019	SELL	$27.84 - $38.92 $734,280 - $1.03 Million	-26,375 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$28.07 - $38.18 $894,141 - $1.22 Million	-31,854 Reduced 54.7%	26,375 $3.14 Million
Q4 2018 Feb 07, 2019	BUY	$26.99 - $37.37 $918,766 - $1.27 Million	34,041 Added 140.74%	58,229 $6.98 Million
Q3 2018 Oct 30, 2018	BUY	$23.35 - $36.72 $564,789 - $888,183	24,188 New	24,188 $3.46 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Dexcom Inc Transaction History